• Users Online: 1647
  • Print this page
  • Email this page
Year : 2022  |  Volume : 21  |  Issue : 2  |  Page : 114-118

C-reactive protein in elderly and pregnant COVID-19 cases: A new role for an old marker

1 Department of Chemistry and Biochemistry, College of Medicine, Mustansiriyah University, Baghdad, Iraq
2 Department of Obstetrics and Gynecology, College of Medicine, Mustansiriyah University, Baghdad, Iraq

Correspondence Address:
Dr. Wassan Nori
Department of Obstetrics and Gynecology, College of Medicine, Mustansiriyah University, Baghdad
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mj.mj_54_22

Rights and Permissions

The clinical characteristics and prognosis of high-risk groups, including elderly and pregnant women, may vary according to the overall susceptibility of novel coronavirus. For that, numerous researchers worldwide have concentrated their efforts on finding a trustworthy biomarker that can determine the severity, prognosis, and survival of those affected. C-reactive protein (CRP), an inflammatory biomarker that showed higher levels in coronavirus 2019 (COVID-19) cases, underlay inflammation degree and was used to gauge the severity of COVID-19. In this review, we discuss whether CRP might have other uses in COVID-19 cases besides predicting the severity and the clinical outcomes among vulnerable risk groups. Doctors must analyze CRP levels along with the period of illness to identify those liable for rapid progress and be able to categorize case severity to guide the clinical decision to improve prognosis.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded73    
    Comments [Add]    

Recommend this journal